Are Peptides Legal? A Country-by-Country Guide to Peptide Regulations
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Product dossiers, research guides, and catalog entries ordered by their latest update date.
Chronological feed of updated product dossiers and research guides.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Everything about the Wolverine Stack — the popular BPC-157 and TB-500 peptide combination used for accelerated recovery. Protocols, dosing, timing, and what users report.
Everything you need to know about BPC-157 — the gastric pentadecapeptide studied for gut healing, tendon repair, and tissue recovery. Mechanisms, research, safety, and practical considerations.
A detailed comparison of BPC-157 and TB-500 (Thymosin Beta-4) — two of the most researched healing peptides. Mechanisms, benefits, stacking, and which one is right for your situation.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
Adipotide, also known as FTPP (CKGGRAKDC-GG-D(KLAKLAK)₂), is a synthetic research peptide designed as a targeted proapoptotic compound and binds to prohibitin receptors on the vascular system of adipose tissue.
AHK (Tripeptide-3) is a research peptide that consists of the tripeptide Ala-His-Lys and is studied with respect to its effects on the function of dermal fibroblasts and the regulation of extracellular matrix genes.
AHK-Cu is a research peptide complex composed of Ala-His-Lys, bound to copper(II), and its role in remodeling the extracellular matrix and activation of fibroblasts is being investigated.
AICAR is a research compound (5-Aminoimidazole-4-carboxamide ribonucleotide) that acts as an AMP analogue and activates the AMP-activated protein kinase (AMPK).
AOD-9604 is a research peptide derived from amino acids 177–191 of the sequence of human growth hormone.
ARA-290 is a synthetic research peptide developed from the B-helix domain region of erythropoietin.
B7-33 is a single-chain peptide analog of the Relaxin family, derived from human H2-relaxin, and aims to selectively activate the RXFP1 receptor without engaging RXFP2.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
BPC-157 is a research peptide composed of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a fragment of the Body Protective Compound that occurs in gastric juice.
The combination of BPC-157 and TB-500 combines two well-characterized research peptides that have been studied with respect to their roles in cellular repair, angiogenesis, and tissue remodeling.
BPC-157 and TB-500 is a research peptide mixture consisting of two cytoprotective peptides, and whose influence on angiogenic and cytoskeletal signals is being studied.
The combination of BPC-157 and TB-500 combines two well-characterized research peptides that have been studied with respect to their roles in cellular repair, angiogenesis, and tissue remodeling.
The Glow Blend combines three research peptides, BPC-157, TB-500, and GHK-Cu, formulated for studies on cellular repair, angiogenesis, and regulation of the extracellular matrix.
BPC-157 5mg, TB-500 (Thymosin Beta-4) 5mg, GHK-Cu 20mg (30mg Total Glow Blend) Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 60mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling.
BPC-157 10mg, TB-500 (Thymosin Beta-4) 10mg, GHK-Cu 40mg (60mg Total Glow Blend) Click here BPC-157, TB-500, GHK-Cu (Glow Blend) 30mg Mechanisms and Synergy BPC-157: A stable gastric pentadecapeptide that has been shown to accelerate angiogenesis, fibroblast migration, and epithelial repair by modulating the VEGFR2- and FAK-Paxillin pathways and nitric oxide signaling.
The Klow Blend combines four research peptides, BPC-157, TB-500, KPV, and GHK-Cu, that are formulated for studies on cellular repair, immunomodulation, and regulation of the extracellular matrix.
Bronchogen is a peptide bioregulator derived from bronchial tissue extracts, and its influence on the regeneration of the respiratory epithelium as well as the gene expression of alveolar cells is studied.
Cardiogen is a peptide bioregulator derived from heart tissue extracts and composed of short amino acid chains that regulate gene expression in the myocardium and the synthesis of contractile proteins.
Cartalax is a peptide bioregulator complex that was isolated from cartilage tissue, and whose role in the synthesis of the extracellular matrix as well as the gene expression of chondrocytes is being studied.
Chonluten is a synthetic peptide bioregulator derived from lung tissue extracts and composed of short amino acid sequences that modulate respiratory gene expression and oxidative reactions.
CJC-1295 (no DAC) and GHRP-2 is a research peptide mixture designed to investigate the synergistic stimulation of the growth hormone axis through two receptor pathways.
CJC-1295 (without DAC) and GHRP-6 is a research peptide mixture that combines GHRH and ghrelin receptor agonists to produce a synergistic stimulation of the GH axis.
CJC-1295 (without DAC) and Hexarelin are a research peptide mixture that combines GHRH receptor and ghrelin receptor agonists to model growth hormone signaling.
CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture that combines two mechanistically distinct secretagogues that act synergistically on the growth hormone axis.
CJC-1295 (without DAC), Ipamorelin and GHRP-2 is a research peptide mixture that has been formulated to investigate synergistic mechanisms of growth hormone release through dual receptor activation.
CJC-1295 (without DAC) (Modified GRF) is a research peptide, also known as Mod GRF (1–29), a tetra-substituted analogue of the growth hormone-releasing hormone (GHRH 1–29), developed for improved stability and receptor affinity, without DAC conjugation.
CJC-1295 (non-DAC), also known as Mod GRF (1–29), is a tetra-substituted analog of the growth hormone-releasing hormone (GHRH 1–29) developed to improve metabolic stability and receptor affinity without DAC conjugation.
CJC-1295 (no DAC), also known as Mod GRF (1-29), is a tetra-substituted analogue of the growth hormone-releasing hormone (GHRH 1-29) developed for improved stability and receptor affinity without modification of the Drug-Affinity-Complex (DAC).
Cortagen is a peptide bioregulator derived from extracts of the cerebral cortex and studied for its role in neuroprotection and neuronal differentiation.
Decapeptide-12 is a research peptide with the sequence Tyr-Arg-Ser-Ala-Asp-Gly-Tyr-Gln-Gly-Leu, designed to inhibit tyrosinase and to investigate the regulation of melanogenic enzymes in vitro.
Dihexa is a synthetic research peptide (N-hexanoic acid-Tyr-Ile-(6)-aminohexanoic acid amide), identified as a mimetic of hepatocyte growth factor (HGF).
DSIP (Delta Sleep-Inducing Peptide) is a research neuropeptide that consists of eight amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu).
Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the natural pineal peptide Epithalamin.
Epithalon (Epitalon) is a research peptide that consists of a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the natural thymus peptide Epithalamin.
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the natural thymus peptide Epithalamin.
Epithalon (Epitalon) is a research peptide composed of the tetrapeptide Ala-Glu-Asp-Gly and derived from the natural thymus peptide Epithalamin.
FGL-S is a synthetic research peptide derived from the sequence of the neuronal cell adhesion molecule (NCAM) and containing the fibroblast growth factor-like domain.
Follistatin 315 is a research peptide isoform of the follistatin protein, consisting of 315 amino acids, and binds and neutralizes activins as well as myostatin in experimental models.
Follistatin 344 is a research peptide variant of the follistatin protein, which contains 344 amino acids, known for binding myostatin and Activin-A and modulating TGF-β signaling.
FOXO4-DRI is a synthetic D-retro-inverse research peptide designed to selectively disrupt the FOXO4–p53 interaction, thereby promoting the clearance of senescent cells in experimental systems.
Fragment, CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture that combines the hGH fragment 176–191 with GHRH- and ghrelin receptor agonists to enable coordinated modeling of the growth hormone axis.
Fragment, Mod GRF and Ipamorelin is a research peptide mixture that combines the hGH fragment 176–191 with GHRH- and ghrelin receptor agonists.
GHK Basic (Tripeptide-1) is a research peptide that consists of the sequence Gly-His-Lys, a naturally occurring fragment that is studied with regard to its role in the regulation of the extracellular matrix and antioxidant defense.
GHK (Gly-His-Lys) is a naturally occurring tripeptide that is studied due to its role in cellular signaling, gene regulation, and remodeling of the extracellular matrix.
GHK-Cu is a naturally occurring copper-binding tripeptide (Gly-His-Lys·Cu²⁺), which has been studied for its role in gene expression, the synthesis of the extracellular matrix, and the regulation of metalloproteins.
GHK-Cu (Copper Tripeptide) (topical) is a research peptide that consists of a naturally occurring tripeptide–copper(II) complex (Gly-His-Lys·Cu²⁺·CH₃COO⁻), which has been studied in depth for its role in regulating the extracellular matrix and redox homeostasis.
GHK-Cu (copper-tripeptide) is a naturally occurring copper-binding tripeptide (Gly-His-Lys-Cu²⁺) that is involved in studies of wound healing, extracellular matrix synthesis, and regulation of metalloproteins.
GHK-Cu is a naturally occurring tripeptide–copper complex (Gly-His-Lys·Cu²⁺·CH₃COO⁻), which is being studied for its role in matrix remodeling and modulation of the antioxidant balance.
GHK-Cu is a research peptide composed of the tripeptide Gly-His-Lys and is complexed with copper(II) ions, forming a naturally occurring peptide-metal complex that is involved in the regulation of the extracellular matrix and tissue remodeling.
GHK-Cu is a research peptide that consists of the tripeptide sequence Gly-His-Lys, which is bound to copper(II) ions, thereby forming a biologically active peptide-metal complex that is studied for its role in modulating the extracellular matrix and cellular signaling.
GHRH (growth hormone-releasing hormone) is a 44-amino-acid hypothalamic research peptide that stimulates the release of growth hormone by activating the GHRH receptor.
GHRP-2 is a synthetic hexapeptide growth hormone secretagogue that binds to the growth hormone secretagog receptor (GHS-R1a), also known as the ghrelin receptor.
GHRP-2 and CJC-1295 without DAC (Mod GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and somatotropic signaling pathways.
GHRP-2 and Ipamorelin are synthetic research peptides that are frequently used together in experimental models to study the regulation of the growth hormone axis and signaling at pituitary receptors.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue.
GHRP-2 is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue.
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that acts as an agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a).
GHRP-6 and CJC-1295 without DAC (Modified GRF 1-29) are synthetic research peptides that are frequently used together in experimental models to investigate the regulation of the growth hormone axis and the signaling mechanisms of the pituitary.
GHRP-6 and Ipamorelin are synthetic research peptides that are frequently used together in experimental models to study the regulation of the growth hormone axis and the signaling of pituitary receptors.
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that acts as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a).
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) that binds to the GHS-R1a receptor and stimulates the release of growth hormone via Gq protein signaling.
Gonadorelin is a research peptide that corresponds to the natural gonadotropin-releasing hormone (GnRH), a decapeptide with the sequence pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂.
Gut inflammation is a research formulation that contains stable BPC-157, KPV, Palmitoylethanolamide (PEA), and tributyrin, and has been developed for studies on intestinal barrier function and modulation of inflammation.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue and an agonist of the ghrelin receptor (GHS-R1a), which is used in experimental models to investigate somatotropic and cardiovascular peptide signaling.
Hexarelin and CJC-1295 without DAC (Mod GRF 1-29) are synthetic research peptides that are used together in experimental models to study the regulation of the growth hormone axis and somatotropic signaling pathways.
Hexarelin and CJC-1295 without DAC (Mod GRF 1-29) are synthetic research peptides used in experimental models to study the regulation of the growth hormone axis and somatotropic signaling pathways.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂) that binds to the GHS-R1a receptor.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂) that binds to the GHS-R1a receptor.
hGH fragment 176–191 is a synthetic research peptide that corresponds to amino acids 177–191 of the sequence of human growth hormone.
Humanin is a mitochondrial-derived research peptide consisting of 24 amino acids (MAPRGFSCLLLLTSEIDLPVKRRA).
IGF-1 LR3 Receptor Grade is a synthetic research peptide analog of human insulin-like growth factor-1, developed with a 13-amino acid residue N-terminal extension to increase receptor affinity and reduce interaction with IGF-binding proteins.
IGF1-LR3 (receptor-grade) is a research peptide analog of human insulin-like growth factor 1, designed with a 13-amino-acid N-terminal extension to improve receptor affinity and resistance to binding proteins.
IGF-1 LR3 is a research peptide analog of human insulin-like growth factor 1 (IGF-1), featuring a 13-amino acid N-terminal extension that improves stability and binding to the IGF-1 receptor.
IGF-1 LR3 is a research peptide analog of human insulin-like growth factor 1 (IGF-1), featuring a 13-amino acid N-terminal extension that improves stability and binding to the IGF-1 receptor.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively binds to the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.
Ipamorelin and CJC-1295 without DAC (Mod GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and mechanisms of somatotropic signaling.
Ipamorelin and CJC-1295 without DAC (modified GRF 1-29) are synthetic research peptides that are used together in experimental models to investigate the regulation of the growth hormone axis and the dynamics of pituitary signaling.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (Aib-His-D-2-Nal-D-Phe-Lys-NH₂), acting as a selective agonist at the ghrelin receptor GHS-R1a.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (Aib-His-D-2-Nal-D-Phe-Lys-NH₂), which acts as a selective agonist at the ghrelin receptor (GHS-R1a).
Ipamorelin is a pentapeptide growth hormone secretagogue (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that selectively acts on the ghrelin receptor (GHS-R1a).
Kisspeptin-10 is a synthetic decapeptide (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂) that corresponds to the active fragment of the KISS1 gene product.
KPV is a synthetic tripeptide fragment derived from the C-terminal sequence of α-MSH.
L-glutathione is a tripeptide (γ-L-glutamyl-L-cysteinylglycine) that serves as a significant intracellular antioxidant and redox regulator.
Livagen is a synthetic peptide bioregulator derived from liver tissue extracts and composed of short amino acid sequences that influence hepatic gene expression and detoxification processes.
LL-37 is a cationic α-helical peptide derived from the C-terminal region of human cathelicidin (hCAP18).
Longevity, Performance & Obesity Research is a research peptide formulation developed to investigate metabolic regulation, mitochondrial function, and nutrient-sensing pathways.
Matrixyl is a palmitoylated pentapeptide (Pal-Lys-Thr-Thr-Lys-Ser) that is studied for its regulatory effects on the synthesis of the extracellular matrix and skin signaling.
Melanostatin DM is a research peptide analog of the tripeptide Prolyl-Leucyl-Glycinamide (PLG), which was developed to study modulation of the α-MSH receptor.
Melanotan I is a synthetic linear α-melanotropin analogue (α-MSH) developed to investigate the activation of the melanocortin receptor, in particular MC1R.
Melanotan-2 (MT-2) is a synthetic cyclic heptapeptide (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) that acts as a potent non-selective melanocortin receptor agonist.
Melanotan 2 is a synthetic cyclic heptapeptide (Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) that acts as a potent nonselective melanocortin receptor agonist.
Methylene blue is a phenothiazine-derived research compound that is widely used worldwide in studies of mitochondrial function, redox biology, and cellular respiration.
MGF is a splice variant of insulin-like growth factor-1 (IGF-1Ec), expressed in response to mechanical overload and cellular stress.
Mod GRF and GHRP-2 is a research peptide mixture that combines GHRH and ghrelin receptor agonists for the experimental modeling of the GH axis.
Mod GRF and GHRP-6 is a research peptide mixture that combines activation of the GHRH receptor and the ghrelin receptor to model the secretion of growth hormone.
Mod GRF and Hexarelin is a research peptide mixture that integrates the activation of the GHRH receptor and the signaling of the ghrelin receptor to investigate GH release mechanisms.
Modified GRF 5 mg, Ipamorelin 5 mg (10 mg total mixture)
Mod GRF, Ipamorelin and GHRP-2 is a research peptide mixture aimed at investigating the synergistic regulation of growth hormone secretion via multiple receptor pathways.
MOTS-c is a research peptide that originates from mitochondria and consists of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg).
MOTS-c is a research peptide derived from mitochondria, consisting of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg).
MOTS-c is a mitochondrially derived research peptide that consists of 16 amino acids (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg).
N-Acetyl Epithalon Amidate is a stabilized analog of the pineal gland–derived tetrapeptide Epitalon (Ala-Glu-Asp-Gly), which has been modified to improve bioavailability.
N-Acetyl Selank Amidate is a stabilized analog of the synthetic research peptide Selank, derived from the natural Tuftsin sequence.
N-Acetyl Semax Amidate is a research peptide derived from the ACTH(4–10) fragment, with N-acetylation and C-terminal amidation for improved metabolic stability.
NAD⁺ (Nicotinamide Adenine Dinucleotide) is an essential cellular coenzyme involved in redox metabolism and energy production in all forms of life.
NAD⁺ (Nicotinamide adenine dinucleotide) is an endogenous pyridine nucleotide that is widely used as a reference compound in experimental research focusing on cellular redox reactions and the regulation of metabolic signaling pathways.
NAD⁺ (Nicotinamide Adenine Dinucleotide) is an essential redox coenzyme involved in cellular energy metabolism and mitochondrial homeostasis.
NMN is a research compound that serves as a direct precursor of nicotinamide adenine dinucleotide (NAD⁺), a central cofactor in cellular redox metabolism.
Nonapeptide-1 is a research peptide (Melanostatine-5) that aims to inhibit melanogenesis by blocking the binding of α-MSH to the melanocortin-1 receptor (MC1R).
OS-01 is a synthetic small-molecule research compound developed to modulate cellular senescence-associated signaling pathways.
Ovagen is a peptide bioregulator derived from liver tissue extracts and used in studies of detoxification and cellular regeneration.
Oxytocin is a cyclic nonapeptide (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂) that is synthesized in the hypothalamus and stored in the neurohypophysis.
P21 is a synthetic research peptide derived from a β-amyloid sequence fragment (Aβ₁₆–₂₀) and aims to modulate Tau phosphorylation and neuroprotective signaling pathways in preclinical models.
Pal-AHK is a research peptide composed of the tripeptide Ala-His-Lys and conjugated with palmitic acid to improve skin uptake and bioavailability.
Pal-GHK (Palmitoyl-Tripeptide-1) is a research peptide formed by conjugating Gly-His-Lys with palmitic acid to improve delivery into the skin.
Palmitoyl-Dipeptid-6 is a research peptide composed of a short dipeptide bound to a palmitic acid chain to improve lipophilicity and skin penetration.
Pancragen is a peptide-bioregulator derived from tissue extracts of the pancreas, and its role in modulating endocrine and exocrine gene expression is being studied.
PE-22-28 is a research peptide derived from the C-terminal fragment of the pituitary adenylyl cyclase-activating polypeptide (PACAP 1–38) and consists of the sequence Gly-Ile-Ala-Gly-Ala-Ser-Asp-Arg.
PEG-MGF (PEGylated Mechano-Growth Factor) is a PEGylated splice variant of IGF-1 (IGF-1Ec) developed to extend the stability of the peptide and its half-life for research applications.
Pentapeptide-18 (Leuphasyl) is a research peptide derived from the enkephalin sequence Tyr-D-Ala-Gly-Phe-Leu and is used to investigate neuromodulatory mechanisms in peptide-receptor communication.
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) that has been studied to regulate neuronal differentiation and responses to oxidative stress.
PNC-27 is a research peptide consisting of a p53–MDM2-binding domain that is linked to a membrane-targeting sequence (residues 12–26 of the p53 protein).
Prostamax is a peptide bioregulator derived from prostate tissue extracts and modulates the peptide-mediated regulation of cell differentiation and cell proliferation.
PT-141 (Bremelanotide) is a synthetic research peptide derived from the alpha-melanocyte-stimulating hormone (α-MSH) and developed for improved stability and receptor specificity.
PT-141 is a synthetic melanocortin receptor agonist, structurally derived from the analogue Melanotan II.
Repair and Recovery is a research peptide formulation that contains stable BPC-157-arginate and Thymosin-Beta-4 fragment and is designed to investigate molecular regeneration as well as mechanisms of tissue neogenesis and remodeling.
Rigin (Palmitoyl Tetrapeptide-7) is a research peptide that consists of Gly-Gln-Pro-Arg and is conjugated to palmitic acid, with the aim of modulating cytokine expression and dermal peptide signaling.
Selank is a synthetic research peptide derived from the natural tuftsin sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro).
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the ACTH(4-10) fragment.
Sermorelin is a synthetic investigational peptide that comprises the first 29 amino acids of growth hormone-releasing hormone (GHRH 1–44) and represents its biologically active domain.
Sermorelin is a synthetic research peptide that consists of the first 29 amino acids of growth hormone-releasing hormone (GHRH 1–44) and represents its biologically active domain.
Sermorelin is a synthetic investigational peptide that comprises the first 29 amino acids of growth hormone-releasing hormone (GHRH 1–44) and represents its biologically active domain.
Sermorelin is a synthetic research peptide that corresponds to the first 29 amino acids of the growth hormone-releasing hormone (GHRH 1-44), representing the biologically active segment responsible for receptor binding.
Sermorelin and GHRP-2 form a research peptide blend designed to investigate a synergistic modulation of growth hormone secretion through complementary receptor pathways.
Sermorelin and GHRP-6 is a research peptide mixture that aims to investigate the cooperative activation of the GHRH- and ghrelin-receptor signaling pathways in pituitary models.
Sermorelin, GHRP-6 and GHRP-2 are a research peptide mixture that combines three different growth hormone secretagogues that act synergistically on the hypothalamic-pituitary axis.
Sermorelin and Ipamorelin are a research peptide mixture that combines a GHRH analog with a ghrelin receptor agonist to study the regulation of growth hormone.
SLU-PP-332 is a small-molecule research compound that has been identified as a selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ).
SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of training by activating estrogen-related receptors (ERRs), in particular ERRα, ERRβ and ERRγ.
SLU-PP-332 is a small-molecule research compound that has been identified as a selective agonist of the peroxisome proliferator-activated receptor delta (PPARδ).
SNAP-8 is a synthetic octapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂), derived from SNAP-25 and aimed at modulating vesicular exocytosis-associated protein interactions.
Syn-AKE is a research peptide modeled after Waglerin-1, a peptide found in the venom of the temple viper, designed as a tripeptide analog that targets subunits of the nicotinic acetylcholine receptor (nAChR) in experimental systems.
Syn-Coll (Palmitoyl-Tripeptid-5) is a research peptide that consists of a tripeptide bound to a palmitic acid chain, with the aim of increasing stability and skin permeability for in vitro studies.
TB-500 (Thymosin Beta-4) is a research peptide that corresponds to a 43-amino-acid sequence of Thymosin Beta-4, an actin-binding protein involved in cytoskeletal organization and tissue regeneration.
TB-500 (Thymosin Beta-4) is a research peptide that corresponds to a 43-amino-acid sequence of Thymosin Beta-4, an actin-binding protein involved in cytoskeletal organization and tissue regeneration.
TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide sequence.
TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide sequence.
TB-500 (Thymosin Beta-4) is a research peptide that corresponds to a 43-amino-acid sequence of Thymosin Beta-4, an actin-binding protein involved in cytoskeletal organization and tissue regeneration.
TB-500 Fragment (17-23) is a research peptide consisting of a short amino acid sequence derived from the actin-binding region of Thymosin Beta-4.
Tesamorelin is a synthetic research peptide and a stabilized analogue of growth hormone-releasing hormone (GHRH), designed to selectively activate the GHRH receptor and stimulate endogenous growth hormone secretion in experimental models.
Tesamorelin is a stabilized synthetic peptide analogue of growth hormone-releasing hormone (GHRH 1–44).
Tesamorelin, CJC-1295 (without DAC) and Ipamorelin are a research peptide mixture formulated to investigate modulation of the growth hormone axis through combined GHRH- and ghrelin-receptor pathways.
Tesamorelin and Ipamorelin form a research peptide mixture aimed at exploring a synergistic activation of the growth hormone axis through two receptor mechanisms.
Tesofensine is a synthetic small-molecule research compound that is classified as a triple monoamine reuptake inhibitor of serotonin, norepinephrine, and dopamine.
Testagen is a peptide bioregulator that has been isolated from testicular tissue extracts, and its effects on gene expression, which are associated with steroidogenesis and spermatogenetic function, are investigated.
Thymogen (Thymogen Alpha-1 Fragment) is a synthetic dipeptide (Glu-Trp) derived from thymic extracts and is associated with regulatory activity in preclinical research.
Thymalin is a polypeptide complex isolated from thymus extracts and consisting of short amino acid chains that play a role in immunoregulatory research.
Thymosin Alpha-1 is a synthetic polypeptide consisting of 28 amino acids and derived from the thymic hormone Thymosin Fraction 5.
Thymosin Alpha-1 is a natural regulator of immune function.
Thymosin Alpha-1 is a natural regulator of immune function.
Thymosin-Beta-4-Fragment (1-4) (Ac-SDKP) is a synthetic research peptide that corresponds to a segment of Thymosin-Beta-4, a 43-amino-acid-long actin-binding protein involved in the organization of the cytoskeleton.
Thyrotropin-releasing hormone (TRH or Protirelin) is a research peptide composed of the tripeptide sequence pGlu-His-Pro-NH₂.
Thyrotropin-releasing hormone (TRH or Protirelin) is a small peptide hormone produced in the hypothalamus.
Thyrotropin-releasing hormone (TRH or Protirelin) is a small peptide hormone produced in the hypothalamus.
Tripeptide-29 is a research peptide composed of Gly-Pro-Hyp, a collagen-derived tripeptide fragment, whose role in the synthesis of the extracellular matrix and the regulation of fibroblasts is being investigated.
Triptorelin is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH; pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2).
Vesilute is a synthetic peptide complex that was isolated from bladder tissue extracts.
Vesugen is a synthetic, short peptide bioregulator derived from extracts of vascular tissue and consisting of amino acid sequences that influence endothelial function and vascular gene expression.
Vialox (Pentapeptide-3V) is a research peptide designed as a synthetic pentapeptide analog modeled after proteins from snake venom to study neuromuscular transmission and receptor-mediated peptide signaling.
Vilon is a short research peptide (Lys-Glu) derived from thymic extracts and known for its role in studies on modulation of gene expression.
VIP (vasoactive intestinal peptide) is a 28-amino-acid neuropeptide that acts as a potent endogenous ligand for VPAC1 and VPAC2 receptors.